RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Securities

A collection of news and information related to Securities published by this site and its partners.

Top Securities Articles see all

Displaying items 1-5
  • Ex-Nvidia manager settles U.S. SEC charges on illegal tips

    NEW YORK/WASHINGTON (Reuters) - A former accounting manager for Nvidia Corp has settled with the U.S. Securities and Exchange Commission over allegations he leaked non-public information about the chipmaker that allowed a group of Wall Street analysts to make millions through illegal trades, the SEC announced on Wednesday.
  • Special Report: For private deals, no one is watching the watchdogs

    OMAHA, Nebraska (Reuters) - From 2006 to 2009, Provident Asset Management raised $485 million from 7,700 investors who were drawn to its promises of annual returns as high as 18 percent on oil and gas assets. Law firm Mick & Associates helped. Provident...

    Settlement time for U.S. trades closer to being shortened

    NEW YORK (Reuters) - The Depository Trust & Clearing Corporation, which processes all U.S. stock and fixed income trades, said on Wednesday it supports shortening the settlement cycle for U.S. equities, corporate and municipal bonds, and unit investment...

    Man pleads guilty to securities fraud in Disney's Marvel acquisition

    Man pleads guilty to securities fraud in Disney's Marvel acquisition
    A San Francisco man pleaded guilty to a single count of securities fraud Monday related to the 2009 acquisition of Marvel Entertainment by Walt Disney Co, federal authorities said.  The announcement by the U.S. attorney's office for the Central District...

    Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...